In vivo selective and distant killing of cancer cells, using adenovirus‐mediated decorin gene transfer
暂无分享,去创建一个
R. Iozzo | C. Evaristo | H. Veiga-Fernandes | E. Schönherr | L. Schaefer | H. Kresse | C. Danel | Miroslava Micegova | P. Lemarchand | S. Kayal | J. Guilherme Tralhão
[1] J. Ménissier-de murcia,et al. Active Caspase-8 Translocates into the Nucleus of Apoptotic Cells to Inactivate Poly(ADP-ribose) Polymerase-2* , 2002, The Journal of Biological Chemistry.
[2] A. Evdokiou,et al. Chemotherapeutic agents sensitize osteogenic sarcoma cells, but not normal human bone cells, to apo2l/trail‐induced apoptosis , 2002, International journal of cancer.
[3] R. Iozzo,et al. Suppression of tumorigenicity by adenovirus-mediated gene transfer of decorin , 2002, Oncogene.
[4] D. Tyrrell,et al. Hepatitis C virus replication in mice with chimeric human livers , 2001, Nature Medicine.
[5] P. Sime,et al. Proteoglycans decorin and biglycan differentially modulate TGF-beta-mediated fibrotic responses in the lung. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[6] G. Evan,et al. Proliferation, cell cycle and apoptosis in cancer , 2001, Nature.
[7] R. D'Amato,et al. Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Opolon,et al. AdTIMP-2 inhibits tumor growth, angiogenesis, and metastasis, and prolongs survival in mice. , 2001, Human gene therapy.
[9] C. Yoo,et al. Adenovirus expressing p27(Kip1) induces growth arrest of lung cancer cell lines and suppresses the growth of established lung cancer xenografts. , 2001, Lung cancer.
[10] H. Gröne,et al. Small proteoglycans in human diabetic nephropathy: discrepancy between glomerular expression and protein accumulation of decorin, biglycan, lumican, and fibromodulin , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] M. Schmidt,et al. Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. , 2001, American journal of respiratory and critical care medicine.
[12] R. Iozzo,et al. An Anti-oncogenic Role for Decorin , 2000, The Journal of Biological Chemistry.
[13] M. Nugent,et al. Sustained Down-regulation of the Epidermal Growth Factor Receptor by Decorin , 2000, The Journal of Biological Chemistry.
[14] M. Steiner,et al. Growth inhibition of prostate cancer by an adenovirus expressing a novel tumor suppressor gene, pHyde. , 2000, Cancer research.
[15] D. Lawrence,et al. Apo2L/TRAIL-dependent recruitment of endogenous FADD and caspase-8 to death receptors 4 and 5. , 2000, Immunity.
[16] S. Woo,et al. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[17] N. Glazer,et al. Angiopoietin-1 protects the adult vasculature against plasma leakage , 2000, Nature Medicine.
[18] G. Kroemer,et al. Apoptosis and cell cycle: distinct checkpoints with overlapping upstream control. , 2000, Pathologie-biologie.
[19] J. Roth,et al. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells , 2000, Oncogene.
[20] Michael T. Fisher,et al. Molecular determinants of response to TRAIL in killing of normal and cancer cells. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] J. Minna,et al. Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer. , 2000, Cancer research.
[22] E Marshall,et al. Gene Therapy Death Prompts Review of Adenovirus Vector , 1999, Science.
[23] A. Loercher,et al. In vitro growth inhibition of ovarian cancer cells by decorin: synergism of action between decorin and carboplatin. , 1999, Cancer research.
[24] T. Kawula,et al. Examination of Early Interactions betweenHaemophilus ducreyi and Host Cells by Using Cocultured HaCaT Keratinocytes and Foreskin Fibroblasts , 1999, Infection and Immunity.
[25] D. Warburton,et al. Adenovirus-mediated decorin gene transfer prevents TGF-β-induced inhibition of lung morphogenesis. , 1999, American journal of physiology. Lung cellular and molecular physiology.
[26] D. Warburton,et al. Adenovirus-mediated decorin gene transfer prevents TGF-beta-induced inhibition of lung morphogenesis. , 1999, The American journal of physiology.
[27] J. Minna,et al. Induction of apoptosis and inhibition of tumorigenicity and tumor growth by adenovirus vector-mediated fragile histidine triad (FHIT) gene overexpression. , 1999, Cancer research.
[28] J. Hsieh,et al. Adenovirus-Mediated p21(WAF1/SDII/CIP1)Gene Transfer Induces Apoptosis of Human Cervical Cancer Cell Lines , 1999, Journal of Virology.
[29] R. Iozzo,et al. Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.
[30] W. Muller,et al. Intratumoral coinjection of adenoviral vectors expressing IL-2 and IL-12 results in enhanced frequency of regression of injected and untreated distal tumors , 1998, Gene Therapy.
[31] R. Crystal,et al. Gene therapy for oxidant injury-related diseases: adenovirus-mediated transfer of superoxide dismutase and catalase cDNAs protects against hyperoxia but not against ischemia-reperfusion lung injury. , 1998, Human gene therapy.
[32] P. Opolon,et al. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[33] L. Nielsen,et al. Recombinant E1-deleted adenovirus-mediated gene therapy for cancer: efficacy studies with p53 tumor suppressor gene and liver histology in tumor xenograft models. , 1998, Human gene therapy.
[34] A. Ribas,et al. In vivo therapy of hepatocellular carcinoma with a tumor-specific adenoviral vector expressing interleukin-2. , 1997, Human gene therapy.
[35] R. Gentz,et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. , 1997, Science.
[36] B. Calabretta,et al. Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. , 1997, The Journal of clinical investigation.
[37] M. Buendia,et al. The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice , 1997, Oncogene.
[38] Y. Kaneda,et al. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.
[39] S. Elledge,et al. In vivo gene therapy with p53 or p21 adenovirus for prostate cancer. , 1995, Cancer research.
[40] T Skorski,et al. De novo decorin gene expression suppresses the malignant phenotype in human colon cancer cells. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[41] M. Perricaudet,et al. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[42] C. S. Lee,et al. Molecular analysis of the p53 alleles in primary hepatocellular carcinomas and cell lines. , 1991, Oncogene.
[43] J. R. McLain,et al. Isolation, culture, and transplantation of human hepatocytes. , 1982, Journal of the National Cancer Institute.
[44] K. Paigen,et al. A simple, rapid, and sensitive DNA assay procedure. , 1980, Analytical biochemistry.
[45] J. Schittny,et al. Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. , 1999, European journal of cell biology.
[46] R. Iozzo,et al. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.
[47] R. Crystal,et al. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. , 1997, Human gene therapy.